Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Detection reagent used for endometriosis uterina

A technology for detecting reagents and endometrium, applied in the fields of biotechnology and medical testing, can solve problems such as reproductive endocrine dysfunction, controversy, premature ovarian failure, etc., to reduce the recurrence of endometriosis, good sensitivity and specificity. Effect

Inactive Publication Date: 2013-05-15
THE OBSTETRICS & GYNECOLOGY HOSPITAL OF FUDAN UNIV
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Studies have shown that multiple recurrences and surgical treatment can cause reproductive endocrine dysfunction and premature ovarian failure. The recurrence of endometriosis has become a very difficult problem in clinical treatment.
However, the reasons for the recurrence of endometriosis are not well understood at present, and the current rAFS staging system cannot achieve the purpose of predicting recurrence, and the results of relevant epidemiological investigations on high-risk factors for recurrence are also quite controversial , so clinically there is still a lack of a method that can be used to detect endometriosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection reagent used for endometriosis uterina
  • Detection reagent used for endometriosis uterina
  • Detection reagent used for endometriosis uterina

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] 1) Selection of genes related to endometriosis

[0043] Select endometriosis-related genes ERα, PR, PR-B, NF-κB p65, and COX-2, and use immunohistochemical SP method to verify the related genes in the ex vivo specimens of patients with endometriosis relapse group and untreated patients. There was differential expression in the recurrence group;

[0044] 2) In vitro verification experiment

[0045] Collect clinical history data to determine the recurrence group and non-relapse group of endometriosis:

[0046] Collect the medical history data of patients with endometriosis confirmed by surgical pathology, including general demographic characteristics, past history, symptom history, surgical conditions, postoperative adjuvant treatment, etc., and follow up regularly every 3 months after surgery, and follow up for 30 consecutive months Above, understand the prognosis and judge whether it is recurrence or not;

[0047] The definition of recurrence of endometriosis describ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a detect reagent for the endometriosis uterine disease, which belongs to the fields of biotechnology and medical inspection. A PR-B mouse anti human monoclonal antibody or / and an NF-Kappa B p5 mouse anti human monoclonal antibody are adopted for being made into the detect reagent and a detect reagent kit. The effect for forecasting the disease palindromia is obtained through detecting the differential expression of relational genes of the endometriosis uterine, such as ERa, PR, PR-B, NF-Kappa B p65 and COX-2 in an internal ectopia palindromia group and a non-palindromia group, and the sensibility, the specificity, the positive predicted value and the negative predicted value are respectively 86.8 percent, 82.1 percent, 0.82 and 0.87. The invention is convenient tocarry out, is favorable to the early diagnosis of the endometriosis uterine disease, and can achieve the purposes for improving and prognosing through the early diagnosis, thereby providing basic reference data for further showing the molecular mechanism on internal ectopia palindromia.

Description

technical field [0001] The invention belongs to the field of biotechnology and medical inspection, and relates to a detection reagent for endometriosis. Background technique [0002] Endometriosis (referred to as endometriosis) is a common disease that seriously affects the quality of life of women of childbearing age. The main clinical manifestations are dysmenorrhea, chronic pelvic pain and infertility. Surgical treatment is currently the first choice for clinical treatment of endometriosis, but clinical practice shows that the recurrence rate is still as high as 40-50% 5 years after surgery, and most patients need a second surgical treatment. Studies have shown that multiple recurrences and surgical treatment can cause reproductive endocrine dysfunction and premature ovarian failure. The recurrence of endometriosis has become a very difficult problem in clinical treatment. However, the reasons for the recurrence of endometriosis are not well understood at present, and t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/577
Inventor 刘惜时郭孙伟袁蕾沈芳华
Owner THE OBSTETRICS & GYNECOLOGY HOSPITAL OF FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products